Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Stern

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Pediatric Pulmonology|June 23, 1998
Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalenceC A Demko, R C Stern, C F Doershuk
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1986
Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosisR C Stern, F C Rothstein, C F Doershuk
European Journal of Respiratory Diseases|October 1, 1983
B-lymphocyte function in cystic fibrosisR U Sorensen, O Ruuskanen, K Miller, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1977
Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosisG H Goldsmith, R C Stern, H Saito, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1991
The action of halothane on stimulus-secretion coupling in clonal (GH3) pituitary cellsR C Stern, J Herrington, C J Lingle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1991
Halothane inhibits two components of calcium current in clonal (GH3) pituitary cellsJ Herrington, R C Stern, A S Evers, et al.
Biochimica Et Biophysica Acta|April 19, 1978
Effect of blood group determinants on binding of human salivary mucous glycoproteins to influenza virusT F Boat, J Davis, R C Stern, et al.
Human Pathology|October 1, 1989
The pathology of fungal infection and colonization in patients with cystic fibrosisV Bhargava, J F Tomashefski, R C Stern, et al.
Clinical Pediatrics|September 1, 1972
Use of a "heparin lock" in the intermittent administration of intravenous drugs. A technical advance in intravenous therapyR C Stern, S Pittman, C F Doershuk, et al.
Infection and Immunity|February 1, 1979
Defective cellular immunity to gram-negative bacteria in cystic fibrosis patientsR U Sorensen, R C Stern, P Chase, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Pediatric Pulmonology|June 23, 1998
Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalenceC A Demko, R C Stern, C F Doershuk
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1986
Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosisR C Stern, F C Rothstein, C F Doershuk
European Journal of Respiratory Diseases|October 1, 1983
B-lymphocyte function in cystic fibrosisR U Sorensen, O Ruuskanen, K Miller, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1977
Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosisG H Goldsmith, R C Stern, H Saito, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1991
The action of halothane on stimulus-secretion coupling in clonal (GH3) pituitary cellsR C Stern, J Herrington, C J Lingle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1991
Halothane inhibits two components of calcium current in clonal (GH3) pituitary cellsJ Herrington, R C Stern, A S Evers, et al.
Biochimica Et Biophysica Acta|April 19, 1978
Effect of blood group determinants on binding of human salivary mucous glycoproteins to influenza virusT F Boat, J Davis, R C Stern, et al.
Human Pathology|October 1, 1989
The pathology of fungal infection and colonization in patients with cystic fibrosisV Bhargava, J F Tomashefski, R C Stern, et al.
Clinical Pediatrics|September 1, 1972
Use of a "heparin lock" in the intermittent administration of intravenous drugs. A technical advance in intravenous therapyR C Stern, S Pittman, C F Doershuk, et al.
Infection and Immunity|February 1, 1979
Defective cellular immunity to gram-negative bacteria in cystic fibrosis patientsR U Sorensen, R C Stern, P Chase, et al.
Pageof 15